Viewing Study NCT07250269


Ignite Creation Date: 2025-12-24 @ 11:05 PM
Ignite Modification Date: 2026-01-13 @ 3:46 AM
Study NCT ID: NCT07250269
Status: RECRUITING
Last Update Posted: 2025-11-26
First Post: 2025-10-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis
Sponsor: Gracell Biotechnologies (Shanghai) Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module